Susi Roger E. 4

What Happened

• Roger E. Susi, identified as a 10% owner of IRADIMED Corp (IRMD), sold a total of 7,500 shares in open‑market transactions on March 30, 2026, generating approximately $712,614 in proceeds. The sale breaks down as: 5,848 shares at a weighted average $94.81 (≈ $554,449), 1,497 shares at $95.66 (≈ $143,203), and 155 shares at $96.53 (≈ $14,962). These were sales (not purchases), which are often routine dispositions rather than an explicit bullish signal.

Key Details

• Transaction date: March 30, 2026; Form 4 filed April 1, 2026 (filed timely).
• Reported weighted-average prices and proceeds:
  • 5,848 shares @ $94.81 = $554,449 (trades ranged $94.36–$95.23; reporting person will provide breakdown on request) [F2]
  • 1,497 shares @ $95.66 = $143,203 (trades ranged $95.40–$96.36) [F3]
  • 155 shares @ $96.53 = $14,962 (trades ranged $96.50–$97.16) [F4]
• Total shares sold: 7,500; total reported proceeds ≈ $712,614.
• Shares owned after transaction: Not specified in the provided Form 4 excerpt.
• Notable footnotes: Sales were executed pursuant to a Rule 10b5‑1 trading plan adopted Nov 5, 2025 [F1]. The reporting person disclaims beneficial ownership except to the extent of pecuniary interest [F5].
• Timeliness: Filing appears timely (Form 4 filed within the normal 2-business-day window).

Context

• The trades were made under a pre-arranged Rule 10b5‑1 plan, which typically means the sales were scheduled in advance and may reduce the immediacy of any inference about insider sentiment.
• As a 10% owner (not identified here as an officer or director), these transactions are subject to Section 16 reporting rules; the F5 disclaimer notes limited claimed beneficial ownership.
• For retail investors: sales by large owners can be routine (tax planning, diversification, planned liquidity). Purchases generally carry more weight as a positive signal; these are sales carried out under a trading plan.